TSE:OGI - OrganiGram Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$3.54
  • Forecasted Upside: 31.16 %
  • Number of Analysts: 8
  • Breakdown:
  • 3 Sell Ratings
  • 4 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
C$2.70
▼ -0.07 (-2.53%)

This chart shows the closing price for OGI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New OrganiGram Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OGI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OGI

Analyst Price Target is C$3.54
▲ +31.16% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for OrganiGram in the last 3 months. The average price target is C$3.54, with a high forecast of C$5.00 and a low forecast of C$2.65. The average price target represents a 31.16% upside from the last price of C$2.70.

This chart shows the closing price for OGI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 8 contributing investment analysts is to hold stock in OrganiGram. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/5/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
9/3/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 2 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 3 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 3 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
10/28/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
11/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/25/2021Raymond JamesSet Price TargetOutperformC$5.00
11/24/2021Alliance Global PartnersLower Price TargetUnderperformC$3.75 ➝ C$3.00
11/24/2021ATB CapitalLower Price TargetC$4.25 ➝ C$2.65
11/24/2021Canaccord GenuityLower Price TargetC$3.50 ➝ C$3.00
11/19/2021Raymond JamesSet Price TargetOutperformC$5.00
9/24/2021CIBCReiterated RatingNeutral
9/23/2021CIBCLower Price TargetNAC$4.00 ➝ C$3.50
9/15/2021Raymond JamesReiterated RatingOutperformC$5.00
9/3/2021Jefferies Financial GroupBoost Price TargetC$3.57 ➝ C$3.83
8/5/2021Raymond JamesReiterated RatingOutperformC$5.00
7/23/2021Atb Cap MarketsReiterated RatingSector Perform
7/14/2021Raymond JamesReiterated RatingOutperformC$5.00
7/14/2021ATB CapitalBoost Price TargetNAC$3.75 ➝ C$4.25
7/14/2021CIBCBoost Price TargetC$3.75 ➝ C$4.00
7/9/2021CIBCReiterated RatingNeutralC$3.75
7/8/2021Raymond JamesReiterated RatingOutperformC$5.00
6/11/2021CIBCBoost Price TargetUnderperformC$3.25 ➝ C$3.75
5/11/2021CIBCUpgradeUnderperform ➝ Neutral
5/11/2021Royal Bank of CanadaUpgradeNeutral
5/4/2021Raymond JamesReiterated RatingOutperformC$5.00
4/22/2021Jefferies Financial GroupBoost Price TargetC$3.48 ➝ C$3.57
4/15/2021Alliance Global PartnersLower Price TargetUnderpeformC$4.00 ➝ C$3.75
4/14/2021Haywood SecuritiesLower Price TargetUnderperformC$4.75 ➝ C$3.50
4/14/2021Canaccord GenuityBoost Price TargetUnderperformC$2.00 ➝ C$3.50
4/14/2021ATB CapitalLower Price TargetUnderperformC$4.20 ➝ C$3.75
4/14/2021Alliance Global PartnersBoost Price TargetUnderperformC$3.75 ➝ C$4.00
4/14/2021CIBCDowngradeNeutral ➝ UnderperformC$5.00 ➝ C$3.25
4/13/2021Raymond JamesLower Price TargetOutperformC$6.00 ➝ C$5.00
4/7/2021Raymond JamesReiterated RatingOutperformC$6.00
4/6/2021CIBCReiterated RatingNeutralC$5.00
3/12/2021Raymond JamesBoost Price TargetOUTPERFORMC$3.00 ➝ C$6.00
3/12/2021ATB CapitalBoost Price TargetNAC$1.90 ➝ C$4.20
3/12/2021CIBCBoost Price TargetNAC$4.25 ➝ C$5.00
3/12/2021Eight CapitalBoost Price TargetNAC$2.40 ➝ C$3.85
1/22/2021Jefferies Financial GroupLower Price TargetMarket PerformC$3.48
1/13/2021Alliance Global PartnersDowngradeBuy ➝ Neutral
1/13/2021Canaccord GenuityDowngradeSpeculative Buy ➝ HoldC$2.50 ➝ C$2.00
1/13/2021Eight CapitalLower Price TargetC$3.50 ➝ C$2.00
1/11/2021Raymond JamesUpgradeMarket Perform ➝ OutperformC$3.00
12/8/2020Raymond JamesReiterated RatingMarket PerformC$3.00
12/4/2020Jefferies Financial GroupBoost Price TargetC$3.79 ➝ C$3.89
12/1/2020CIBCBoost Price TargetC$2.00 ➝ C$2.25
12/1/2020Haywood SecuritiesLower Price TargetHoldC$2.50 ➝ C$2.00
11/23/2020Raymond JamesLower Price TargetMarket PerformC$5.00 ➝ C$3.00
10/1/2020Raymond JamesSet Price TargetMarket PerformC$5.00
9/16/2020Cantor FitzgeraldBoost Price TargetC$5.00 ➝ C$5.35
8/5/2020Jefferies Financial GroupLower Price TargetC$4.50 ➝ C$3.79
7/23/2020Eight CapitalLower Price TargetC$4.00 ➝ C$3.50
7/22/2020Raymond JamesSet Price TargetMarket PerformC$5.00
7/22/2020ATB CapitalDowngradeOutperform ➝ Sector PerformC$4.10 ➝ C$2.30
7/22/2020Canaccord GenuityLower Price TargetC$5.00 ➝ C$3.00
7/22/2020CIBCLower Price TargetC$2.75 ➝ C$2.00
7/22/2020CormarkLower Price TargetC$3.50 ➝ C$2.25
7/21/2020Pi FinancialReiterated RatingBuy
7/21/2020AltaCorp CapitalDowngradeOutperform ➝ Sector Perform
7/7/2020Alliance Global PartnersReiterated RatingBuyC$4.00
7/6/2020Jefferies Financial GroupLower Price TargetC$5.00 ➝ C$4.50
6/29/2020Raymond JamesDowngradeOutperform ➝ Market PerformC$6.50 ➝ C$5.00
6/1/2020Raymond JamesSet Price TargetOutperformC$6.50
5/17/2020Raymond JamesSet Price TargetOutperformC$6.50
4/23/2020Raymond JamesSet Price TargetOutperformC$6.50
4/16/2020Jefferies Financial GroupLower Price TargetC$5.50 ➝ C$5.00
4/15/2020Canaccord GenuityLower Price TargetC$6.50 ➝ C$5.00
4/15/2020CIBCDowngradeOutperform ➝ NeutralC$5.00 ➝ C$2.75
4/15/2020Haywood SecuritiesLower Price TargetC$5.50 ➝ C$4.75
4/15/2020Pi FinancialLower Price TargetBuyC$7.00 ➝ C$5.50
4/15/2020AltaCorp CapitalUpgradeSector Perform ➝ OutperformC$5.50 ➝ C$4.10
4/15/2020Eight CapitalLower Price TargetC$7.00 ➝ C$4.00
4/15/2020Stifel NicolausLower Price TargetC$10.00 ➝ C$6.00
4/14/2020Raymond JamesLower Price TargetOutperformC$9.00 ➝ C$6.50
4/8/2020Raymond JamesSet Price TargetOutperformC$9.00
3/24/2020Raymond JamesSet Price TargetOutperformC$9.00
1/20/2020Jefferies Financial GroupBoost Price TargetC$5.00 ➝ C$5.50
1/16/2020Pi FinancialSet Price TargetBuyC$7.00
1/15/2020Raymond JamesSet Price TargetOutperformC$9.00
1/10/2020CIBCLower Price TargetC$9.00 ➝ C$5.00
1/9/2020Raymond JamesDowngradeOutperform ➝ Market PerformC$9.00
1/2/2020Jefferies Financial GroupLower Price TargetC$8.20 ➝ C$5.00
11/26/2019AltaCorp CapitalDowngradeOutperform ➝ Sector Perform
11/26/2019CormarkLower Price TargetC$10.00 ➝ C$4.50
11/26/2019Haywood SecuritiesLower Price TargetC$8.00 ➝ C$7.50
11/26/2019Pi FinancialSet Price TargetBuyC$7.00
11/26/2019Raymond JamesSet Price TargetOutperformC$9.00
11/25/2019Beacon SecuritiesDowngradeBuy ➝ Hold
11/13/2019Raymond JamesSet Price TargetOutperformC$9.00
11/13/2019Canaccord GenuityLower Price TargetC$8.50 ➝ C$7.00
11/12/2019AltaCorp CapitalLower Price TargetC$13.15 ➝ C$6.50
11/5/2019Cantor FitzgeraldReiterated RatingOverweight
10/11/2019Jefferies Financial GroupUpgradeHold ➝ BuyC$10.50 ➝ C$8.20
9/24/2019CIBCSet Price TargetOutperformC$9.00
6/2/2019AltaCorp CapitalReiterated RatingOutperform
5/3/2019Jefferies Financial GroupDowngradeBuy ➝ HoldC$10.00 ➝ C$10.50
4/17/2019CormarkBoost Price TargetSpeculative BuyC$8.50 ➝ C$10.50
4/16/2019Canaccord GenuityBoost Price TargetC$8.50 ➝ C$10.50
2/25/2019Jefferies Financial GroupSet Price TargetBuyC$10.00
1/29/2019CormarkBoost Price TargetC$5.50 ➝ C$8.50
1/29/2019Pi FinancialBoost Price TargetC$8.00 ➝ C$10.00
12/19/2018Canaccord GenuityBoost Price TargetBuy ➝ AverageC$6.00 ➝ C$7.50
10/16/2018Beacon SecuritiesSet Price TargetBuyC$12.00
3/12/2018Eight CapitalBoost Price TargetC$4.50 ➝ C$7.00
3/7/2018Canaccord GenuitySet Price TargetC$5.50
10/12/2017Canaccord GenuityBoost Price TargetC$3.10 ➝ C$3.60
12/8/2016GMP SecuritiesUpgradeHold ➝ Buy
12/8/2016MackieBoost Price TargetC$2.00 ➝ C$4.35
(Data available from 11/28/2016 forward)

News Sentiment Rating

0.23 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/2/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/1/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/1/2021
  • 8 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
7/31/2021
  • 4 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/30/2021
  • 4 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
9/29/2021
  • 2 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
10/29/2021
  • 3 very positive mentions
  • 29 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
11/28/2021

Current Sentiment

  • 3 very positive mentions
  • 29 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
OrganiGram logo
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers cannabis flowers, extracts, edibles and oils, beverages, and other cannabis products for adult recreational market under the Edison Reserve, Edison Cannabis Co., ANKR Organics, and Trailblazer brands; and medical cannabis products, including strains, cannabis oils, extracts, edibles, beverages, and vaporizers for the medical market. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Read More

Today's Range

Now: C$2.70
Low: C$2.65
High: C$2.79

50 Day Range

MA: C$2.85
Low: C$2.37
High: C$3.18

52 Week Range

Now: C$2.70
Low: C$1.56
High: C$8.00

Volume

1,648,115 shs

Average Volume

2,731,613 shs

Market Capitalization

C$809.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of OrganiGram?

The following Wall Street analysts have issued reports on OrganiGram in the last year: Alliance Global Partners, Atb Cap Markets, ATB Capital, Canaccord Genuity, CIBC, Eight Capital, Haywood Securities, Jefferies Financial Group Inc., Raymond James, and Royal Bank of Canada.
View the latest analyst ratings for OGI.

What is the current price target for OrganiGram?

8 Wall Street analysts have set twelve-month price targets for OrganiGram in the last year. Their average twelve-month price target is C$3.54, suggesting a possible upside of 31.2%. Raymond James has the highest price target set, predicting OGI will reach C$5.00 in the next twelve months. ATB Capital has the lowest price target set, forecasting a price of C$2.65 for OrganiGram in the next year.
View the latest price targets for OGI.

What is the current consensus analyst rating for OrganiGram?

OrganiGram currently has 3 sell ratings, 4 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in OGI, but not buy more shares or sell existing shares.
View the latest ratings for OGI.

How do I contact OrganiGram's investor relations team?

The company's listed phone number is 844-644-4726. The official website for OrganiGram is www.organigram.ca.